Fri, Sep 06, 2024
Stock of the Day: Today Anil Singhvi gave buying advice in Marksans Pharma. What is stoploss and targets? See in this video.
More >
Tue, Apr 16, 2024
Massachusetts Institute of Technology acquired 66 lakh shares of the pharma at an average price of Rs 158 apiece, as per the bulk deal data on the National Stock Exchange (NSE). This took the deal value to Rs 104.28 crore.
Fri, Jan 20, 2023
Marksans Pharma raised ₹372.4 Cr through warrants. Marksans Pharma issued warrants to OrbiMed and the promoters. OrbiMed is a global healthcare investment company.
Thu, Oct 13, 2022
Marksans Pharma share price: With an aim to increase the formulation business amid improved demand, Small-cap pharma company Marksans Pharma Limited on Tuesday entered into a business transfer agreement with Goa-based Tevapharm India Private Limited.
Tue, Aug 16, 2022
The company’s gross profit was at Rs 218.9 crore, growing by over 17 per cent YoY with a gross margin at 50.5 per cent YoY, the pharma company said.
Sat, Jun 12, 2021
In a conversation with Anil Singhvi, Managing Editor at Zee Business, Devanshi Ashar, Research Analyst and Anchor said that from last year Marksans Pharma is witnessing good gains and now the company's board members are going to meet on June 15.
Mon, Sep 26, 2016
The company said that USFDA has granted not for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filled capsules 10 mg.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
